Literature DB >> 2210985

Volume change of the prostate and seminal vesicles in male hypogonadism after androgen replacement therapy.

I Sasagawa1, T Nakada, T Kazama, S Satomi, T Terada, T Katayama.   

Abstract

Before and after androgen replacement therapy prostatic and seminovesicular volume was estimated by means of transrectal ultrasonography in 13 hypogonadal men. Volume of the prostate (p less than 0.001) and seminal vesicles (p less than 0.01) significantly increased after treatment with testosterone enanthate. However, the plasma level of testosterone remained abnormally low. These results indicate that volume determination of the prostate and seminal vesicles by means of transrectal ultrasonography is suitable for evaluating the adequacy of androgen replacement therapy in male hypogonadism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2210985     DOI: 10.1007/bf02550407

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  9 in total

Review 1.  Examination of the hypothesis that a direct control system exists for the prostate and seminal vesicles.

Authors:  C G Pierrepoint; P Davies; M H Lewis; D B Moffat
Journal:  J Reprod Fertil       Date:  1975-08

Review 2.  Endocrine control and physiology of the prostate.

Authors:  A A Sandberg
Journal:  Prostate       Date:  1980       Impact factor: 4.104

3.  Development and application of new equipment for transrectal ultrasonography.

Authors:  H Watanabe; D Igari; Y Tanahasi; K Harada; M Saito
Journal:  J Clin Ultrasound       Date:  1974-06       Impact factor: 0.910

4.  Transrectal ultrasonic volume determination of the prostate--a preoperative and postoperative study.

Authors:  S M Hastak; J Gammelgaard; H H Holm
Journal:  J Urol       Date:  1982-06       Impact factor: 7.450

5.  Hormonal replacement and sexuality in men.

Authors:  J M Davidson; M Kwan; W J Greenleaf
Journal:  Clin Endocrinol Metab       Date:  1982-11

6.  Volume estimation of the seminal vesicles by means of transrectal ultrasonotomography: a preliminary report.

Authors:  Y Tanahashi; H Watanabe; D Igari; K Harada; M Saitoh
Journal:  Br J Urol       Date:  1975-12

7.  Randomized clinical trial of testosterone replacement therapy in hypogonadal men.

Authors:  A J Conway; L M Boylan; C Howe; G Ross; D J Handelsman
Journal:  Int J Androl       Date:  1988-08

8.  Effects of testosterone replacement on sexual behavior in hypogonadal men.

Authors:  P Salmimies; G Kockott; K M Pirke; H J Vogt; W B Schill
Journal:  Arch Sex Behav       Date:  1982-08

Review 9.  The use and misuse of androgens.

Authors:  J D Wilson; J E Griffin
Journal:  Metabolism       Date:  1980-12       Impact factor: 8.694

  9 in total
  5 in total

Review 1.  Testosterone and benign prostatic hyperplasia.

Authors:  Thomas R Jarvis; Bilal Chughtai; Steven A Kaplan
Journal:  Asian J Androl       Date:  2015 Mar-Apr       Impact factor: 3.285

2.  The European Academy of Andrology (EAA) ultrasound study on healthy, fertile men: Prostate-vesicular transrectal ultrasound reference ranges and associations with clinical, seminal and biochemical characteristics.

Authors:  Francesco Lotti; Francesca Frizza; Giancarlo Balercia; Arcangelo Barbonetti; Hermann M Behre; Aldo E Calogero; Jann-Frederik Cremers; Felice Francavilla; Andrea M Isidori; Sabine Kliesch; Sandro La Vignera; Andrea Lenzi; Marios Marcou; Adrian Pilatz; Olev Poolamets; Margus Punab; Maria Fernanda Peraza Godoy; Claudia Quintian; Osvaldo Rajmil; Gianmaria Salvio; Osama Shaeer; Wolfgang Weidner; Elisa Maseroli; Sarah Cipriani; Elisabetta Baldi; Selene Degl'Innocenti; Giovanna Danza; Anna Lucia Caldini; Alessandro Terreni; Luca Boni; Csilla Krausz; Mario Maggi
Journal:  Andrology       Date:  2022-07-19       Impact factor: 4.456

3.  Relationship between serum total testosterone and prostate volume in aging men.

Authors:  Bo-Wen Xia; Si-Cong Zhao; Zong-Ping Chen; Chao Chen; Tian-Shu Liu; Fan Yang; Yong Yan
Journal:  Sci Rep       Date:  2021-07-08       Impact factor: 4.379

4.  6'-Sialyllactose Ameliorates In Vivo and In Vitro Benign Prostatic Hyperplasia by Regulating the E2F1/pRb-AR Pathway.

Authors:  Bo-Ram Jin; Hyo-Jung Kim; Eun-Yeong Kim; Tae-Wook Chung; Ki-Tae Ha; Hyo-Jin An
Journal:  Nutrients       Date:  2019-09-12       Impact factor: 5.717

Review 5.  Review of the Roles and Interaction of Androgen and Inflammation in Benign Prostatic Hyperplasia.

Authors:  Yu Tong; Ren-Yuan Zhou
Journal:  Mediators Inflamm       Date:  2020-10-28       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.